Dataset from A Phase II, Multicenter, Open-label, Three-cohort Trial Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma (BCC)

Name: Dataset from A Phase II, Multicenter, Open-label, Three-cohort Trial Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma (BCC)
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-02 收录

下载链接：

https://doi.org/10.25934/00005768

下载链接

链接失效反馈

官方服务：

资源简介：

This was a 3-cohort, open-label study of vismodegib (GDC-0449) in new (non-recurrent) operable basal cell carcinoma of the nodular subtype.

创建时间：

2025-02-22